Accueil > Actualité
Actualite financiere : Actualite bourse

AstraZeneca: supply contract with Samsung

( - Samsung Biologics, the biopharmaceutical division of the South Korean tech giant Samsung, announced on Monday evening that it has signed a big supply contract with AstraZeneca.

The long-term agreement provides for the supply to the Anglo-Swedish laboratory of the main assets for the manufacture of its products, as well as the transfer of certain medicinal products.

The contract will mean a payment of around 330.8 million dollars, which could be increased to 545.6 million dollars if necessary, the Korean bioproduction services company said.

Copyright (c) 2020 All rights reserved.




Qui sommes-nous ? | Nous contacter | FAQ | Mentions légales | RSS | © Copyright 2007 Cercle Finance. Tous droits réservés.
Indices et cours différés d’au moins 15 mn | Cotations boursières fournies par ABC Bourse.